11:34 IST
BSE
Regulatory ApprovalAstraZeneca Pharma India Ltd ASTRAZEN
AstraZeneca Pharma India Regulatory Approval
AstraZeneca Pharma received CDSCO permission to market 'Enhertu' for an additional breast cancer indication in India. This expands the drug's therapeutic usage under regulatory approval.